Eli Lilly and Company logo

Eli Lilly and Company LLY

$ 897.0 -2.11%

Annual report 2025
added 02-12-2026

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

897 M

Market Cap[1]

$ 805 B

EBITDA (LTM)

$ 2.37 B

P/E (LTM)

65.28

P/S (LTM)

15.77

EPS (LTM)

13.74

Eli Lilly and Company is one of the world's largest pharmaceutical companies, specializing in the development, manufacturing, and sale of innovative drugs for the treatment of various diseases.

The company was founded in 1876 in Indianapolis, Indiana and has since become a leader in the pharmaceutical industry. Eli Lilly and Company develops and manufactures a wide range of drugs, including those for diabetes, cancer, mental disorders, Alzheimer's disease, and other illnesses.

One of the company's most well-known developments is insulin, which was created in 1923. This drug became the first effective treatment for diabetes and has saved millions of lives worldwide.

Eli Lilly and Company actively invests in research and development of new drugs to help patients worldwide fight various diseases. The company also aims to improve the quality of life for patients by providing them with access to high-quality drugs. Is a global company with operations in more than 125 countries. The company cares about its employees and society as a whole, participating in various charitable projects and social responsibility programs.

Overall, is one of the most successful and innovative companies in the pharmaceutical industry. Its products help millions of people worldwide overcome difficulties associated with various diseases and improve their quality of life.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Amarin Corporation plc Amarin Corporation plc
AMRN
$ 14.67 -0.07 % $ 6.09 B Nasdaq Global Market irlandaIrlanda
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Aileron Therapeutics Aileron Therapeutics
ALRN
- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Atreca Atreca
BCEL
- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
bluebird bio bluebird bio
BLUE
- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Cabaletta Bio Cabaletta Bio
CABA
$ 2.82 1.44 % $ 283 M Nasdaq Global Select Market usaUSA
Avid Bioservices Avid Bioservices
CDMO
- - $ 789 M Nasdaq Capital Market usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.29 -3.01 % $ 329 M Nasdaq Global Select Market britainBritain
CEL-SCI Corporation CEL-SCI Corporation
CVM
$ 3.47 -1.7 % $ 221 M NYSE American,SPB usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Denali Therapeutics Denali Therapeutics
DNLI
$ 19.74 -12.17 % $ 3.25 B Nasdaq Global Select Market,SPB usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChemoCentryx ChemoCentryx
CCXI
- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
$ 1.09 -9.17 % $ 22.4 M Nasdaq Capital Market israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
- - $ 40.5 M Nasdaq Capital Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
Equillium Equillium
EQ
$ 2.06 - $ 118 M Nasdaq Global Market usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
$ 2.85 3.26 % $ 592 M Nasdaq Global Market,SPB usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
$ 23.45 -1.64 % $ 631 M Nasdaq Global Market usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
$ 1.32 -5.2 % $ 1.88 M Nasdaq Global Select Market chinaChina
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
$ 47.55 0.98 % $ 4.28 B Nasdaq Global Market,SPB schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
$ 4.45 -1.77 % $ 853 M Nasdaq Global Select Market canadaCanada
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.